Diabetic Nephropathy: A Comprehensive Review for Health Care Professionals

International Journal of Digital Evidence Pub Date : 2020-11-23 DOI:10.46715/ijde2020.11.1000108

Sumon Rahman Chowdhur

{"title":"Diabetic Nephropathy: A Comprehensive Review for Health Care Professionals","authors":"Sumon Rahman Chowdhur","doi":"10.46715/ijde2020.11.1000108","DOIUrl":null,"url":null,"abstract":"The prevalence of Chronic Kidney Disease (CKD) continues to escalate at an alarming rate and diabetes has become the most common single cause of End-Stage Renal Disease (ESRD) in the world. This is because diabetes, particularly type 2, is increasing in prevalence, and the patients are living longer now. Diabetes is the major cause of end-stage renal disease in the developed world, accounting for 40% to 50% of cases.\n\nDiabetic nephropathy contributes significantly to the economic burden of diabetes. In UK, the cost of diabetic complications in 2011/2012 was estimated at £14 billion, by 2035/2036 this is expected to rise to £22 billion. Worldwide, healthcare costs for diabetic patients are much higher than non- diabetic patients. Also, among diabetic patients the cost of health care is much higher in those with complications (Micro < Macro<Micro + Macrovascular complications) than in those without complications, therefore identifying and controlling diabetes and its complications is essential in reducing the burden of the disease.\n\nIn this review we shall explore the pathophysiology, risk factors, staging, screening, management and prognosis of Diabetic Nephropathy in explicit details to make it easily understandable for the Health Care Professionals.\n\n\nKeywords: Diabetic Nephropathy, Diabetes, Health Care Professionals","PeriodicalId":341642,"journal":{"name":"International Journal of Digital Evidence","volume":"32 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Digital Evidence","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46715/ijde2020.11.1000108","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

The prevalence of Chronic Kidney Disease (CKD) continues to escalate at an alarming rate and diabetes has become the most common single cause of End-Stage Renal Disease (ESRD) in the world. This is because diabetes, particularly type 2, is increasing in prevalence, and the patients are living longer now. Diabetes is the major cause of end-stage renal disease in the developed world, accounting for 40% to 50% of cases. Diabetic nephropathy contributes significantly to the economic burden of diabetes. In UK, the cost of diabetic complications in 2011/2012 was estimated at £14 billion, by 2035/2036 this is expected to rise to £22 billion. Worldwide, healthcare costs for diabetic patients are much higher than non- diabetic patients. Also, among diabetic patients the cost of health care is much higher in those with complications (Micro < Macro

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

糖尿病肾病:卫生保健专业人员的综合综述

慢性肾脏疾病(CKD)的患病率持续以惊人的速度上升，糖尿病已成为世界上最常见的终末期肾脏疾病(ESRD)的单一原因。这是因为糖尿病，尤其是2型糖尿病的发病率正在上升，而且患者的寿命也在延长。在发达国家，糖尿病是导致终末期肾病的主要原因，占所有病例的40%至50%。糖尿病肾病是糖尿病经济负担的重要组成部分。在英国，2011/2012年糖尿病并发症的费用估计为140亿英镑，到2035/2036年，预计这一数字将上升到220亿英镑。在世界范围内，糖尿病患者的医疗费用远高于非糖尿病患者。此外，在糖尿病患者中，有并发症的患者(微血管<宏观血管<微血管+大血管并发症)的医疗保健费用远高于无并发症的患者，因此，识别和控制糖尿病及其并发症对于减轻疾病负担至关重要。在这篇综述中，我们将探讨糖尿病肾病的病理生理，危险因素，分期，筛查，管理和预后的明确细节，使其更容易理解卫生保健专业人员。关键词:糖尿病肾病，糖尿病，医护人员

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

International Journal of Digital Evidence

自引率

0.00%

发文量